CLDN14 antibody (C-Term)

Catalog No. ABIN184791

This anti-CLDN14 antibody is a Goat Polyclonal antibody detecting CLDN14 in WB and ELISA. Suitable for Human.

Quick Overview for CLDN14 antibody (C-Term) (ABIN184791)

Target: CLDN14 (Claudin 14 (CLDN14))

Reactivity: Human

Host: Goat

Clonality: Polyclonal

Conjugate: This CLDN14 antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Grade: Verified

Product Details anti-CLDN14 Antibody

Binding Specificity: C-Term

Purpose: Claudin 14 / CLDN14

Sequence: SATHSGYRLN DYV

Specificity: Reported variants represent identical protein (NP_036262.1, NP_652763.1, NP_001139551.1, NP_001139550.1 and NP_001139549.1).

Cross-Reactivity: Cow, Dog, Human, Mouse, Pig, Rat

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Immunogen: C-SATHSGYRLNDYV

Isotype: IgG

Application Details

Application Notes:

Western Blot: Approx 23 kDa band observed in Human Liver Lysate (calculated MW of 25.7 kDa according to NP_652763.1). Recommended concentration: 0.3-1 μg/mL.

Peptide ELISA: antibody detection limit dilution 1:4000.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Minimize freezing and thawing.

Storage: -20 °C

Storage Comment: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Target Details for CLDN14

Target: CLDN14 (Claudin 14 (CLDN14))

Alternative Name: CLDN14

Background: CLDN14, claudin 14, DFNB29, OTTHUMP00000109046, OTTHUMP00000109047, OTTHUMP00000109048, OTTHUMP00000109049

Gene ID: 23562, 56173

NCBI Accession: NP_036262

Pathways: Cell-Cell Junction Organization, Hepatitis C